The hot flashes drug pipeline is expanding, driven by rising menopause cases, demand for non-hormonal therapies, and innovations in neurokinin receptor antagonists and hormone modulators. https://ayema.ng/blogs/202102/Hot-Flashes-Drug-Pipeline-Analysis-Trend-Size-and-Future-Growth